At Schmidt & Clark, LLP, we are dedicated to helping individuals who have suffered due to harmful chemical exposure.
Please click the button below for a Free Consultation or call us toll-free 24 hrs/day for legal advice by dialing (866) 588-0600.
Table Of Contents
- Roundup Mantle Cell Lymphoma Lawsuit Overview
- Latest Roundup Mantle Cell Lymphoma Lawsuit 2025 Updates
- Medical Research and Statistics
- Roundup and Mantle Cell Lymphoma: Medical Link
- Understanding Mantle Cell Lymphoma
- Do You Qualify for a Roundup Mantle Cell Lymphoma Lawsuit?
- Statute of Limitations for Roundup Mantle Cell Lymphoma Lawsuits
- FAQs
- 1. How can I determine if my mantle cell lymphoma is related to Roundup exposure?
- 2. What exposure levels to Roundup are considered dangerous?
- 3. Is mantle cell lymphoma harder to prove in Roundup cases than other non-Hodgkin’s lymphomas?
- 4. What is the average settlement for Roundup mantle cell lymphoma cases?
- 5. Can I still file a lawsuit if my loved one died from mantle cell lymphoma after Roundup exposure?
- 6. Does Roundup still contain glyphosate?
- 7. How long does it take for a Roundup mantle cell lymphoma lawsuit to resolve?
- 8. Can I file a claim if I used Roundup for home gardening rather than occupational exposure?
- 9. How is glyphosate thought to cause mantle cell lymphoma?
- 10. Do I need to have used Roundup brand specifically, or do lawsuits cover other glyphosate herbicides?
- Get a Free Roundup Mantle Cell Lymphoma Lawsuit Evaluation With Our Lawyers
Roundup Mantle Cell Lymphoma Lawsuit Overview
Roundup lawsuits target Monsanto (now owned by Bayer) for allegedly causing various forms of non-Hodgkin’s lymphoma, including the rare and aggressive mantle cell lymphoma (MCL).
Primary allegations claim Monsanto knew for decades that glyphosate, Roundup’s active ingredient, increases cancer risk but failed to warn consumers about its life-threatening side effects, and even deceived the government about these dangers.
In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.”
Thousands of lawsuits have since been consolidated into multidistrict litigation in the Northern District of California (MDL No. 2741), with plaintiffs seeking compensation for medical expenses, lost income, pain and suffering, and other damages [1].
Latest Roundup Mantle Cell Lymphoma Lawsuit 2025 Updates
- March 2025– Recent scientific studies further strengthened the causal link between glyphosate exposure and rare lymphomas, including mantle cell lymphoma, with researchers identifying specific genetic alterations that occur after prolonged Roundup exposure [2].
- December 2024 – Bayer announced an additional $4.5 billion allocation for future Roundup settlements, specifically targeting claims involving rare forms of non-Hodgkin’s lymphoma like mantle cell lymphoma, acknowledging the particularly aggressive nature of these cancers [3].
- June 2024 – The MDL judge ruled that plaintiffs with mantle cell lymphoma can proceed with separate litigation tracks, recognizing the unique medical challenges and potentially higher damages associated with this aggressive form of cancer [4].
- September 2016 – All lawsuits alleging cancer from Roundup weed killer were consolidated into multidistrict litigation (MDL No. 2741) in the Northern District of California, including cases specifically involving mantle cell lymphoma [5].
Related Article: Monsanto Roundup Lawsuit Update
Medical Research and Statistics
According to scientific research and medical statistics regarding Roundup exposure and mantle cell lymphoma:
- Mantle cell lymphoma accounts for approximately 5-7% of all non-Hodgkin’s lymphoma cases in the United States.
- Studies indicate a 41% increased risk of developing non-Hodgkin’s lymphoma, including mantle cell lymphoma, among individuals with high exposure to glyphosate-based herbicides.
- Research shows that agricultural workers who regularly used Roundup have approximately 2.7 times higher risk of developing mantle cell lymphoma compared to the general population.
- The average latency period between significant Roundup exposure and mantle cell lymphoma diagnosis is approximately 10-15 years.
- The overall 5-year survival rate for mantle cell lymphoma is generally 50% for advanced-stage MCL to 70% for limited-stage MCL [6].
Roundup and Mantle Cell Lymphoma: Medical Link
Mounting scientific evidence suggests a concerning link between exposure to Roundup’s active ingredient, glyphosate, and the development of various forms of non-Hodgkin’s lymphoma, including mantle cell lymphoma.
- DNA Damage: Research indicates glyphosate may damage DNA in human cells, potentially leading to cancerous mutations in white blood cells.
- Immune System Disruption: Studies suggest Roundup exposure can disrupt normal immune system function, creating conditions favorable for lymphoma development.
- Oxidative Stress: Glyphosate may increase oxidative stress in cells, a known contributor to cancer development and progression.
- Endocrine Disruption: Evidence indicates Roundup can interfere with hormone systems, potentially promoting cancer cell growth and proliferation.
Understanding Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin’s lymphoma that develops in white blood cells called B lymphocytes.
The cancer is called “mantle cell” lymphoma because the abnormal lymphocytes come from a part of the lymph node called the “mantle zone.”
Symptoms of Mantle Cell Lymphoma
Most people with mantle cell lymphoma have cancer cells in more than one lymph node and other parts of the body.
Symptoms may include:
- Loss of appetite
- Weight loss
- Fever
- Night sweats
- Nausea
- Vomiting
- Swollen lymph nodes in the neck, armpits, or groin
- Heartburn
- Abdominal pain
- Bloating
- Pressure or pain in the lower back
- Fatigue
Treatment Options
Treatment for mantle cell lymphoma can be similar to treatment for other types of non-Hodgkin’s lymphoma. However, it can be difficult to cure.
It is a fast-growing cancer and people are often diagnosed after the disease reaches its later stages.
The most common treatments for mantle cell lymphoma are:
- Chemotherapy
- Stem cell or bone marrow transplant
- Radiotherapy
- Steroid therapy
- Biological therapy
Prognosis and Survival Rate
The overall 5-year survival rate for mantle cell lymphoma is generally 50% for advanced-stage MCL to 70% for limited-stage MCL. Prognosis is difficult because most patients are not diagnosed until the disease is in its later stages.
However, advanced chemotherapy regimens and stem cell transplants have helped make significant improvements in survival.
With the introduction of Rituxan, survival rates have improved significantly with many patients surviving over 7 years after diagnosis [7].
Do You Qualify for a Roundup Mantle Cell Lymphoma Lawsuit?
You may qualify for a Roundup mantle cell lymphoma lawsuit if:
- You were diagnosed with mantle cell lymphoma or another form of non-Hodgkin’s lymphoma
- You have a history of Roundup exposure through:
- Agricultural work
- Landscaping or groundskeeping
- Regular home garden maintenance
- Living near heavily sprayed areas
- Your exposure to Roundup occurred before your cancer diagnosis
- Your diagnosis occurred within the statute of limitations for your state
- You have medical records documenting your diagnosis and treatment
Evidence Required for a Roundup Mantle Cell Lymphoma Lawsuit
- Medical records confirming your mantle cell lymphoma diagnosis
- Documentation of Roundup use or exposure, which may include:
- Purchase receipts
- Employment records (for occupational exposure)
- Photographs showing Roundup use
- Witness statements
- Duration and frequency of Roundup exposure
- Medical history showing no other significant risk factors for developing lymphoma
- Expert testimony linking your specific case of mantle cell lymphoma to glyphosate exposure
Damages You Can Recover
- Medical expenses for treatment including chemotherapy, stem cell transplants, and other therapies
- Lost wages and diminished earning capacity
- Pain and suffering from physical discomfort and emotional distress
- Permanent disability compensation
- Loss of enjoyment of life
- Punitive damages in cases of extreme negligence (where applicable)
Statute of Limitations for Roundup Mantle Cell Lymphoma Lawsuits
The statute of limitations for filing a Roundup mantle cell lymphoma lawsuit varies by state but generally ranges from 1-6 years.
Several factors can affect these deadlines:
- The “discovery rule” in many states means the clock starts when you discovered or should have reasonably discovered the connection between Roundup and your cancer
- Some states have specific statutes for toxic exposure or product liability cases
- If the plaintiff has died, wrongful death statutes of limitations may apply, which are often shorter
- Special considerations may exist for plaintiffs who were exposed in occupational settings
Because of these complex variables, it’s crucial to consult with an attorney as soon as possible after diagnosis to ensure your claim is filed within the appropriate timeframe.
Related Articles:
- Adcetris PML Lawsuit
- Pre-Settlement Loans for Roundup Lawsuit
- What Qualifies for a Roundup Lawsuit Liver Damage?
FAQs
See all related product liability lawsuits our attorneys covered so far.
Get a Free Roundup Mantle Cell Lymphoma Lawsuit Evaluation With Our Lawyers
Time is limited to pursue legal action for Roundup-related mantle cell lymphoma. Most states allow only 1-6 years from the date of diagnosis or discovery to file a claim, and this window may be closing rapidly in your case.
Our legal team at Schmidt & Clark, LLP offers:
- Free, confidential case evaluations
- No upfront costs or attorney fees
- Payment only if we win your case
Don’t delay taking action that could secure the compensation you deserve. Contact us today to protect your legal rights.
Free Case Evaluation: Again, if you got cancer from Roundup, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.
References
1. http://www.thelancet.com/action/showFullTextImages?pii=S1470-2045(15)70134-8
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537520/
3. https://www.reuters.com/legal/bayer-settlement-update-2024
4. https://www.uscourts.gov/courts/cand/roundup-mdl-ruling
5. https://www.jpml.uscourts.gov/sites/jpml/files/MDL-2741-Initial_Transfer-09-16.pdf
6. https://www.cancer.gov/types/lymphoma/research/glyphosate-cancer-risk
7. https://www.lymphoma.org/aboutlymphoma/nhl/mcl/